000 01815 a2200505 4500
005 20250513204918.0
264 0 _c20000420
008 200004s 0 0 eng d
022 _a0020-7136
024 7 _a10.1002/(sici)1097-0215(20000415)86:2<269::aid-ijc18>3.0.co;2-8
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aAzemar, M
245 0 0 _aRecombinant antibody toxins specific for ErbB2 and EGF receptor inhibit the in vitro growth of human head and neck cancer cells and cause rapid tumor regression in vivo.
_h[electronic resource]
260 _bInternational journal of cancer
_cApr 2000
300 _a269-75 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aADP Ribose Transferases
650 0 4 _aAnimals
650 0 4 _aAntibodies, Monoclonal
650 0 4 _aBacterial Toxins
650 0 4 _aCarcinoma, Squamous Cell
_xchemistry
650 0 4 _aCell Division
650 0 4 _aErbB Receptors
_xanalysis
650 0 4 _aExotoxins
_xadministration & dosage
650 0 4 _aHead and Neck Neoplasms
_xchemistry
650 0 4 _aHumans
650 0 4 _aImmunotoxins
_ximmunology
650 0 4 _aMice
650 0 4 _aMice, Nude
650 0 4 _aNeoplasm Transplantation
650 0 4 _aReceptor, ErbB-2
_xanalysis
650 0 4 _aRecombinant Fusion Proteins
_ximmunology
650 0 4 _aTumor Cells, Cultured
650 0 4 _aVirulence Factors
650 0 4 _aPseudomonas aeruginosa Exotoxin A
700 1 _aSchmidt, M
700 1 _aArlt, F
700 1 _aKennel, P
700 1 _aBrandt, B
700 1 _aPapadimitriou, A
700 1 _aGroner, B
700 1 _aWels, W
773 0 _tInternational journal of cancer
_gvol. 86
_gno. 2
_gp. 269-75
856 4 0 _uhttps://doi.org/10.1002/(sici)1097-0215(20000415)86:2<269::aid-ijc18>3.0.co;2-8
_zAvailable from publisher's website
999 _c10691744
_d10691744